Explore the detailed record of transactions filed by Christensen Jamie, Directeur Scientifique. Officer active across 1 companies, notably Mirati Therapeutics, Inc.. Aggregated, 11 filings have been logged. Total volume traded: €524k. The latest transaction was disclosed on 23 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Jamie Christensen is the Executive Vice President and Chief Scientific Officer at Mirati Therapeutics, Inc. She oversees the company's research and development initiatives. Her role is essential for promoting scientific innovation.